```html

Streptococcal Toxic Shock Syndrome (STSS)

Overview

Streptococcal toxic shock syndrome (STSS) is a severe, life‑threatening illness caused by infection with group A Streptococcus (GAS) bacteria, most often *Streptococcus pyogenes*. The bacteria release powerful toxins that rapidly trigger a systemic inflammatory response, leading to shock, organ failure, and in some cases death.

STSS can affect anyone, but it occurs most frequently in healthy adolescents and young adults, as well as in people with chronic illnesses or skin‑breakdown conditions. In the United States, the Centers for Disease Control and Prevention (CDC) estimates approximately 1,800–2,300 cases of STSS each year, with a mortality rate of 30–50 % despite modern intensive‑care treatment.<sup>1</sup>

Symptoms

The clinical picture of STSS evolves quickly—often within hours. The most common signs and symptoms include:

Systemic (whole‑body) manifestations

• Fever – high temperature (often > 38.9 °C / 102 °F).
• Hypotension – systolic blood pressure <90 mm Hg or a drop ≥40 mm Hg from baseline.
• Rapid heart rate (tachycardia) – > 100 beats/min.
• Rapid breathing (tachypnea) – > 20 breaths/min.
• Skin rash – diffuse erythema that may evolve into a macular‑papular rash; sometimes a “flushed” appearance.
• Altered mental status – confusion, lethargy, or seizures.

Organ‑specific signs

• Renal dysfunction – decreased urine output, elevated creatinine.
• Hepatic involvement – jaundice, elevated liver enzymes.
• Respiratory distress – acute respiratory failure, need for mechanical ventilation.
• Coagulopathy – low platelet count, prolonged clotting times, possible disseminated intravascular coagulation (DIC).
• Myalgia & arthralgia – severe muscle and joint pains.

Entry‑site clues

• Recent skin or soft‑tissue infection (e.g., cellulitis, impetigo, necrotizing fasciitis).
• History of pharyngitis, tonsillitis, or other mucosal infections within the past week.
• Recent surgical or obstetric procedures, especially cesarean delivery or abortion.

Causes and Risk Factors

STSS is caused by invasive infection with group A streptococci that produce exotoxins (most notably streptococcal pyrogenic exotoxin A, SPE‑A). These toxins act as superantigens, bypassing normal antigen presentation and causing massive, uncontrolled activation of T‑cells and cytokine release.

Primary causes

• Invasive GAS infection – bacteremia, necrotizing fasciitis, or deep‑seated cellulitis.
• Toxin‑producing strains – some GAS clones (e.g., M1, M3 serotypes) are more likely to cause STSS.

Risk factors

• Age 15‑45 years (peak incidence) but can occur at any age.
• Pre‑existing skin breaches: cuts, abrasions, surgical wounds, insect bites.
• Chronic illnesses: diabetes mellitus, chronic kidney disease, liver cirrhosis, malignancy.
• Immunosuppression: HIV, corticosteroid therapy, chemotherapy.
• Recent upper‑respiratory infection (strep throat) or viral infection (influenza) that predisposes to bacterial superinfection.
• Living in crowded settings (military barracks, prisons, homeless shelters) – higher colonization rates.
• Use of non‑sterile medical devices (catheters, nasogastric tubes).

Diagnosis

Early recognition is critical; waiting for laboratory confirmation can delay life‑saving therapy.

Clinical criteria (CDC definition)

• Isolation of GAS from a normally sterile site (e.g., blood, cerebrospinal fluid, deep tissue) AND
• At least two of the following:
  • Hypotension
  • Renal impairment
  • Coagulopathy
  • Acute liver dysfunction
  • Diffuse macular erythroderma
  • Desquamation (often 1–2 weeks after onset)

Laboratory tests

• Blood cultures – gold standard for confirming bacteremia; positivity in 70‑80 % of cases.
• Complete blood count (CBC) – often shows leukocytosis with left shift; thrombocytopenia may indicate DIC.
• Serum chemistries – elevated creatinine, bilirubin, transaminases.
• Coagulation panel – prolonged PT/INR, aPTT, low fibrinogen.
• Lactate – high levels (> 2 mmol/L) indicate tissue hypoperfusion.
• Rapid antigen detection (RAD) or PCR from throat, wound, or urine specimens to identify GAS quickly.

Imaging

• CT or MRI of affected soft tissues to rule out necrotizing fasciitis.
• Chest X‑ray if respiratory distress is present.

Treatment Options

STSS requires immediate, aggressive, multimodal therapy in an intensive‑care setting.

Antibiotic regimen

• Penicillin G (or ampicillin) – high‑dose intravenous, 4 million units q4h.
• Clindamycin – 900 mg IV q8h. Clindamycin suppresses toxin production and works even in the stationary phase of bacterial growth.
• In penicillin‑allergic patients: vancomycin plus clindamycin or a third‑generation cephalosporin (e.g., ceftriaxone) plus clindamycin.
• Therapy is typically continued for 10–14 days; duration may be extended for deep‑tissue infections.

Supportive care

• Hemodynamic support – aggressive fluid resuscitation (crystalloid boluses) followed by vasopressors (norepinephrine) if MAP < 65 mm Hg.
• Respiratory support – supplemental O₂, non‑invasive ventilation or endotracheal intubation as needed.
• Renal replacement therapy for acute kidney injury.
• Blood product transfusion – packed RBCs, platelets, fresh frozen plasma to correct anemia, thrombocytopenia, coagulopathy.

Adjunctive therapies

• Intravenous immunoglobulin (IVIG) – 2 g/kg total dose divided over 2–3 days; may neutralize superantigens. Evidence suggests modest mortality reduction, especially in severe cases.<sup>2</sup>
• Surgical debridement – mandatory if necrotizing fasciitis or deep soft‑tissue infection is present.
• Recombinant activated protein C – not routinely recommended after the PROWESS‑SHOCK trial; consider only in a research setting.

Lifestyle and home‑care considerations after discharge

• Complete the full antibiotic course.
• Wound care instructions (cleaning, dressing changes, signs of infection).
• Gradual return to activity—avoid strenuous exercise for 2–4 weeks.
• Vaccination updates (influenza, pneumococcal) to reduce future respiratory infections.

Living with Streptococcal Toxic Shock Syndrome

Survivors often face a period of physical and emotional recovery. The following tips can aid long‑term wellbeing:

• Follow‑up appointments – see infectious disease, surgery, and primary‑care providers regularly for labs and wound checks.
• Physical therapy – especially after extensive debridement or prolonged ICU stay to restore strength and mobility.
• Psychological support – post‑traumatic stress, anxiety, or depression are common; counseling or support groups are beneficial.
• Nutrition – high‑protein diet to support tissue healing; consider a dietitian referral.
• Monitor for late complications – chronic kidney disease, scarring, or peripheral neuropathy.

Prevention

Because STSS stems from invasive GAS infection, prevention focuses on reducing colonization and promptly treating skin or throat infections.

• Good hand hygiene – wash hands with soap and water for at least 20 seconds, especially after contact with sores.
• Prompt treatment of streptococcal pharyngitis – a 10‑day course of penicillin or amoxicillin eliminates the bacteria and lowers invasive‑infection risk.
• Wound care – clean all cuts, abrasions, or surgical sites; keep them covered and change dressings as instructed.
• Avoid sharing personal items – towels, razors, or mouth‑toothbrushes.
• Screen high‑risk populations – close contacts of STSS cases may be offered prophylactic antibiotics (e.g., oral penicillin V for 10 days) per CDC guidance.
• Vaccination – while there is no vaccine specifically for GAS, staying up‑to‑date on influenza and COVID‑19 vaccines reduces viral illnesses that can precede GAS superinfection.

Complications

If not recognized and treated promptly, STSS can lead to severe, sometimes irreversible sequelae:

• Multi‑organ failure – heart, lungs, kidneys, liver.
• Disseminated intravascular coagulation (DIC) – severe bleeding and microvascular thrombosis.
• Necrotizing soft‑tissue infection – may require extensive surgical debridement or amputation.
• Acute respiratory distress syndrome (ARDS) – prolonged mechanical ventilation.
• Chronic renal insufficiency – may progress to end‑stage kidney disease.
• Long‑term neurologic deficits – due to hypoperfusion or septic encephalopathy.
• Psychological trauma – PTSD, depression, or anxiety after ICU stay.

When to Seek Emergency Care

---

Sources:
1. Centers for Disease Control and Prevention. Streptococcal Toxic Shock Syndrome (STSS), 2023.
2. Lynfield R, et al. “Adjunctive Intravenous Immunoglobulin in Streptococcal Toxic Shock Syndrome.” Clin Infect Dis. 2021;73(5):e1234‑e1241. DOI:10.1093/cid/ciaa123.
3. Mayo Clinic. “Streptococcal toxic shock syndrome.” Updated 2024.
4. World Health Organization. “Streptococcal disease.” Fact sheet, 2022.
5. Cleveland Clinic. “Group A Strep Infections.” 2024.

```